Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-19
2005-07-19
Desai, Rita (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S236800, C548S195000, C544S133000
Reexamination Certificate
active
06919361
ABSTRACT:
A 5-membered cyclic compound of the formula:wherein X is oxygen or sulfur, R1is hydrogen, substituted or unsubstituted alkyl, etc., R2is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, etc., Y1is a direct bond, substituted or unsubstituted alkylene, —CO(CH2)n—, etc., the wavy line means (E)-configuration or (Z)-configuration, R3is substituted or unsubstituted aryl, etc., Y2is substituted or unsubstituted alkylene, etc., R4is hydrogen, substituted or unsubstituted alkanoyl, substituted or unsubstituted alkyl, etc., R5is hydrogen, etc., or a salt thereof, these compound being able to inhibit infiltration of leukocytes such as eosinophils and lymphocytes, by which being useful for the treatment of various kinds of inflammation.
REFERENCES:
patent: 941288 (1956-04-01), None
patent: WO 98/26065 (1998-06-01), None
patent: WO98/26065 (1998-06-01), None
patent: WO01/07424 (2001-02-01), None
patent: WO 01/07424 (2001-02-01), None
patent: WO01/32604 (2001-05-01), None
patent: WO 01/42604 (2001-05-01), None
Selwood et al., 2001, CAS:134:353175.
Matsuura et al., 2002, CAS:138:39276.
Christensen et al., 1999, CAS:130:237560.
Nemes, Andras, et al. Acta Chimica Academiae Scientiarum Hungaricae, TOMUS, vol. 78, No. 3, pp. 283-291, 1973.
Acheso, R. Morrin, et al. Journal of Chemical Society, Perkin Transactions 1, vol. 8, pp. 1773-1778, 1980.
Yamamoto, Yuich, et al. Chemical & Pharmaceutical Bulletin, Vo. 32, No. 11, pp. 4292-4299, 1984.
Tsatsas, G., et al., Chimika Chronika New Series 1, vol. 1, No. 3-4, pp. 188-192, 1972.
Kaye et al., J. Am. Chem. Soc., vol. 74, pp. 2921-2922, (1952).
Druey et al., Helv. Chim. Acta, vol. 24, pp. 226E-233E, (1941).
Previtera et al., Farmaco Soc. Chim. Ital., vol. 49, No. 1, pp. 33-40, (1994).
Nemes et al., Acta Chimica Academiae Scientiarum Hungaricae, TOMUS, vol. 78, No. 3, pp. 283-291, (1973).
Acheson et al., Journal of Chemical Society, Perkin Transactions 1, vol. 8, pp. 1773-1778, (1980).
Yamamoto et al., Chemical & Pharmaceutical Bulletin, vol. 32, No. 11, pp. 4292-4299, (1984).
Tsatsas et al., Chimika Chronika New Series 1, vol. 1, No. 3-4, pp. 188-192, (1972).
Antoku Fujio
Fujita Hitoshi
Fujiwara Norio
Kawakami Hajime
Sugasawa Toshinari
Desai Rita
Shiao Robert
Sumitomo Pharmaceuticals Company Limited
LandOfFree
Five-membered-ring compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Five-membered-ring compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Five-membered-ring compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3383046